The burden of presbyopia and reading glasses drives patients to look for solutions.“There is a clear and growing patient ...

Linda Stein Gold, MD, shares insights on new therapeutic options for patients with various psoriasis subtypes and psoriatic arthritis.

Panelists discuss how treatment individualization depends on patient-specific factors including age, comorbidities, disease severity, and personal preferences, balancing clinical guidelines with ...

Editor's note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. So, we have made a very big advance ...

Combination immune checkpoint inhibitor therapy (ICI) with ipilimumab (anti–cytotoxic T-lymphocyte–associated protein 4) + nivolumab (anti–PD-1) in untreated, metastatic melanoma has achieved a ...

ORLANDO, Fla. — A novel topical therapy for axial hyperhidrosis approved by the FDA in June 2024 is among the increasing number of therapeutic options and new protocols for existing options to improve ...

The FDA granted Breakthrough Therapy status to zovegalisib plus Faslodex for patients with PIK3CA-mutated HR+/HER2- advanced breast cancer. The U.S. Food and Drug Administration (FDA) has granted ...

The new understanding of molecular events that drive the various forms of amyloidosis has led to the expansion of therapeutic options to prevent end-stage disease or even offer a cure, which has added ...

Michelle and Dan Krueger took their four-month-old daughter, Elly, to a pediatrician the day before Thanksgiving in 2023. Michelle and Dan understood the childhood development phases from their ...